New Veeva Vault QMS Brings Next-Generation Quality Management to Life Sciences
Veeva Systems (NYSE:VEEV) today unveiled the industry’s first cloud application that unifies quality management processes in life sciences. Veeva Vault QMS replaces disparate, on-premise systems to manage global quality processes across an organization, including external partners. Together with Veeva Vault QualityDocs , Veeva now offers the only integrated suite of quality applications for seamless end-to-end content and quality management, delivering greater visibility and collaboration.
“Quality management solutions are crucial to ensuring product safety and ongoing regulatory compliance,” said Robert Lorence, vice president, Quality and Compliance Services at HighPoint Solutions. “Veeva's new QMS application offers the market a powerful, modern, cloud alternative to existing on-premise quality management systems. In an industry segment continually looking for greater efficiency and effectiveness, this is welcome news.”
Increased global outsourcing of quality manufacturing, combined with intensified regulatory scrutiny, is fueling complexity in the life sciences industry. While the majority of companies have implemented a quality management system, these solutions often reside – and are only accessible – within a company’s four walls1 . This limits visibility and access throughout the entire global supply chain for critical stakeholders, especially external contract manufacturers and partners.
Veeva solves this with a suite of cloud applications – Vault QMS and Vault QualityDocs – that brings together quality processes and documentation throughout the enterprise. The new Vault QMS application incorporates external stakeholders into the full spectrum of quality processes, including deviations, lab investigations, complaints, internal and external audits, corrective and preventive actions, and change control. This reduces compliance risks and eliminates bottlenecks in bringing drugs and treatments to market.
“Quality management is more complicated today, involves more people and geographies, and requires greater transparency for regulatory authorities,” said Michael Jovanis, vice president of Veeva Vault Quality. “Customers struggle to keep quality processes and documentation in sync and incorporate external partners with disparate systems. Vault QMS meets the realities of today’s quality manufacturing environment and connects the entire end-to-end quality process.”
Veeva Vault QMS is the latest application built on Veeva Vault , a cloud platform and suite of applications that provide a single source of truth across the enterprise. Native interoperability between Vault applications empowers life sciences companies to streamline their business processes across an increasingly broad ecosystem of internal and external stakeholders.
Veeva Vault QMS will be available in late June 2016. To learn more about how cloud–based quality solutions are modernizing quality management, register for the upcoming webinar, “Modernizing Quality Management,” and see a live demonstration of Vault QMS on 14 July 2016.
For more on Veeva Vault QMS, visit: veeva.com/eu/QMS
For more on the Veeva suite of quality products, visit: veeva.com/eu/quality
Stay updated on the latest Veeva news on LinkedIn: linkedin.com/company/veeva-systems
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 400 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit veeva.com/eu .
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-K for the period ended January 31, 2016. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
PIERRE-FABRE23.6.2018 13:02 | pressemeddelelse
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress
SERVIER23.6.2018 10:12 | pressemeddelelse
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho
SOFTOMOTIVE22.6.2018 17:15 | pressemeddelelse
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA
TX-ASCEND-PERFORMANCE22.6.2018 16:02 | pressemeddelelse
Ascend Performance Materials Announces Price Increase for Intermediate Materials
DELTICOM-AG/MOTO-TYRES.C22.6.2018 15:43 | pressemeddelelse
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk
BOEHRINGER-INGELHEIM22.6.2018 14:02 | pressemeddelelse
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum